• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 8
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue8

Evaluation Of Hba1c As A Valid Tool For Risk Assessment In Ischemic Stroke And TIA

    Prof. Dr. Pravati Tripathy, Debjani Nayak, Pratibha Khosla Sahil Kumar Anshul Bhateja Ravneet Kaur Sukhminder Singh Gurinder Kaur

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 8, Pages 4773-4777

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Stroke is the second leading cause of death in the world in the last two decades. The present study was conducted to evaluate HbA1C as a valid tool for risk assessment in ischemic stroke and TIA.
Materials & Methods: 50 patients who were diagnosed with acute ischemic stroke or TIA, were included. Diagnosis of acute ischemic stroke was made on CT/MRI scan. Estimation of HbA1C was done by photometric test using ion exchange resin. Estimation of blood glucose level was done by glucose oxidase method.
Results: Group I was non- diabetic having 10, group II was pre- diabetic having 8 and group III was diabetic having 22 patients. There were 30 (60%) males and 20 (40%) females. In group A there were 6 males and 4 females, group B had 10 males and 8 females while in group C there were 14 males and 8 females. The sex distribution amongst the three groups did not reveal any statistical difference, and hence all the three groups were comparable.
Conclusion: HbA1C is a novel marker for determining the glycaemic status of a person. In cases of acute ischemic stroke and TIA, HbA1C should be used as a screening tool in determining the previous glycaemic status, prevalence of prediabetes and differentiate it from stress hyperglycaemia.
Keywords:
    Acute ischemic stroke Diabetes Glucose
  • PDF (310 K)
  • XML
(2021). Evaluation Of Hba1c As A Valid Tool For Risk Assessment In Ischemic Stroke And TIA. European Journal of Molecular & Clinical Medicine, 7(8), 4773-4777.
Prof. Dr. Pravati Tripathy, Debjani Nayak, Pratibha Khosla; Sahil Kumar; Anshul Bhateja; Ravneet Kaur; Sukhminder Singh; Gurinder Kaur. "Evaluation Of Hba1c As A Valid Tool For Risk Assessment In Ischemic Stroke And TIA". European Journal of Molecular & Clinical Medicine, 7, 8, 2021, 4773-4777.
(2021). 'Evaluation Of Hba1c As A Valid Tool For Risk Assessment In Ischemic Stroke And TIA', European Journal of Molecular & Clinical Medicine, 7(8), pp. 4773-4777.
Evaluation Of Hba1c As A Valid Tool For Risk Assessment In Ischemic Stroke And TIA. European Journal of Molecular & Clinical Medicine, 2021; 7(8): 4773-4777.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 217
  • PDF Download: 282
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus